[Preterm birth prediction: sequential evaluation of the cervix and the test for phosphorylated protein-1 linked to

Insights

Sequential testing of cervical length and phosphorylated insulin-like growth factor binding protein-1 (phIGFBP-1) effectively predicts preterm birth. Combining these tests offers high sensitivity and negative predictive value for identifying at-risk pregnancies.

Area of Science:

  • Maternal-fetal medicine
  • Obstetric ultrasound
  • Biomarker analysis

Context:

  • Preterm birth remains a leading cause of neonatal morbidity and mortality.
  • Accurate prediction of preterm birth is crucial for timely intervention and improved outcomes.
  • Asymptomatic pregnant women with a history of premature delivery are at increased risk.

Purpose:

  • To evaluate the predictive utility of sequential cervical length measurements and phosphorylated insulin-like growth factor binding protein-1 (phIGFBP-1) testing for preterm birth.
  • To assess the correlation between these two diagnostic tests.
  • To determine the combined efficacy of these tests in predicting delivery before 37 weeks' gestation.

Summary:

  • Cervical length measurement demonstrated high sensitivity in predicting preterm birth across all evaluated gestational ages.
  • The phIGFBP-1 test became predictive of prematurity from 27 weeks onwards.
  • The sequential combination of cervical length and phIGFBP-1 testing significantly enhanced sensitivity (81.8%) and negative predictive value (93.7%) compared to individual tests.

Impact:

  • The combined sequential assessment of cervical length and phIGFBP-1 offers a robust strategy for predicting preterm birth.
  • This approach can aid clinicians in identifying high-risk pregnancies, enabling targeted management and potentially reducing adverse neonatal outcomes.
  • The findings support the integration of these sequential tests into routine prenatal care for women with a history of preterm delivery.
Abstract